Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Various drugs and toxins in the gastrointestinal tract represent a broad category of exogenous substances rather than a specific endogenous molecular target like a receptor or enzyme. These substances include ingested poisons, drug overdoses, and metabolic byproducts that are targeted by adsorbents, chelators, or ion-exchange resins within the gut lumen. The primary therapeutic goal in targeting these substances is to prevent their absorption into the systemic circulation, thereby mitigating toxicity or managing systemic electrolyte imbalances (StatPearls: Activated Charcoal). For example, activated charcoal is a common intervention that utilizes its vast surface area to non-specifically adsorb a wide array of chemical moieties through van der Waals forces (StatPearls: Gastrointestinal Decontamination). Other agents, such as sevelamer or sodium polystyrene sulfonate, target specific ions like phosphate or potassium to treat chronic conditions like hyperphosphatemia in kidney disease (PubMed: PMID 29939625). Because this "target" is a heterogeneous collection of molecules with diverse chemical structures, it is considered a non-specific pharmacological target used primarily in emergency medicine and nephrology. Safety concerns associated with these interventions include gastrointestinal obstruction and the risk of pulmonary aspiration, particularly with charcoal. Additionally, these binders can interfere with the absorption of necessary therapeutic medications, requiring careful timing of administration (PubMed: PMID 30571001).
Physical adsorption, chemical chelation, or ion exchange within the gastrointestinal lumen to inhibit systemic absorption.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Various drugs and toxins in the gastrointestinal tract.